GDF15 and breast cancer: Using siRNA, GDF15 was transiently knocked down in HER2-positive BT474 empty vector pCMV control, BT474 GDF15-overexpressing stable clone, and triple-negative MDA-MB-231 breast cancer cells, which have endogenous overexpression of GDF15 (Figure 9B).